Stanford University


Showing 21-30 of 476 Results

  • Pooja Kakar

    Pooja Kakar

    Member, Maternal & Child Health Research Institute (MCHRI)

    Current Research and Scholarly InterestsAs a breastfeeding medicine physician, I am passionate about advocating for mother-infant dyads and supporting their breastfeeding journeys. Additionally, I am interested studying and addressing disparities in initiation and duration of breastfeeding, particularly in lower-resourced populations, by building and advancing community partnerships.

    I am also interested in the use of digital health tools to advance upstream determinants of health in community-based settings. My current funded research projects include: 1) Providing a telehealth-based, weight control program to children with obesity from lower-income, racial and ethnic minority families (Gardner GOALS) and 2) Assessing and addressing disparities in healthy behaviors in families from under-resourced settings through the use of a secure, multilingual mobile neighborhood app (Our Voice: Beyond Clinic Walls).

  • Anusha Kalbasi, M.D.

    Anusha Kalbasi, M.D.

    Associate Professor of Radiation Oncology (Radiation Therapy)

    BioDr. Kalbasi is a board-certified radiation oncologist and physician-scientist at the Stanford Cancer Institute. He is also an associate professor of radiation oncology at Stanford Medicine and a project member of the Parker Institute for Cancer Immunotherapy.

    In the clinic, Dr. Kalbasi specializes in the diagnosis and treatment of solid tumors, especially sarcoma and melanoma, with a focus on bringing new treatments to patients. This focus includes using advanced techniques in radiation oncology and cancer immunotherapy.

    Dr. Kalbasi's NIH-funded laboratory studies the cancer-immune interface in various therapeutic contexts, including T cell therapy, cytokine therapy and innate immune agonism. The lab has described tumor cell-, T cell- and myeloid cell-intrinsic mechanisms of resistance to therapy and approaches to overcome therapy resistance. Dr. Kalbasi is also an experienced leader of clinical trials related to immunotherapy, T cell therapy and radiation therapy.

    Prior to his arrival at Stanford Health Care, Dr. Kalbasi was assistant professor of radiation oncology in the David Geffen School of Medicine at UCLA and chief of sarcoma radiotherapy at the UCLA Jonsson Comprehensive Cancer Center. During his tenure, he was named a NextGen Star by the American Association of Cancer Research in recognition for excellence in cancer research.

    Dr. Kalbasi’s work has been published in leading journals including Nature, Science Translational Medicine, JAMA Oncology, Lancet Oncology, Nature Cancer and Cancer Discovery. He has served as a peer reviewer for multiple prestigious journals, including the Proceedings of the National Academy of Sciences, Cell and the Journal of Clinical Investigation. He has also presented research to his peers at the American Association for Cancer Research and the American Institute of Chemical Engineers.

  • Agnieszka Kalinowski

    Agnieszka Kalinowski

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioI am a translational physician-scientist focused on studying the role of the immune system in patients with schizophrenia. My work spans careful clinical characterization of patients to understanding mechanisms in basic science model systems, allowing to provide mechanistic understanding to observations in clinical samples. Currently, I'm focused on deciphering the role of the complement system and how the known genetic risk translates into pathophysiological disease mechanisms. I hope that this work will pave the way to novel treatment strategies.

  • Nathan Kalinowski, D.M.D.

    Nathan Kalinowski, D.M.D.

    Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery

    BioDr. Nathan Kalinowski is a Hospital Dentist and Clinical Assistant Professor in Dental Medicine and Surgery. He performs medically necessary dental clearance and extractions for patients preparing for cardiac surgery, radiation therapy, or organ transplantation. He also performs surgical treatment of infection and trauma to the teeth and supporting alveolar bone including reconstruction using dental implants.

  • Renata Kallosh

    Renata Kallosh

    Stanford W. Ascherman, MD Professor, Emerita

    BioWhat is the mathematical structure of supergravity/string theory and its relation to cosmology?

    Professor Kallosh works on the general structure of supergravity and string theory and their applications to cosmology. Her main interests are related to the models early universe inflation and dark energy in string theory. She develops string theory models explaining the origin of the universe and its current acceleration. With her collaborators, she has recently constructed de Sitter supergravity, which is most suitable for studies of inflation and dark energy and spontaneously broken supersymmetry.

    She is analyzing possible consequences of the expected new data from the Large Hadron Collider (LHC) and the results of current and future cosmological observations, including Planck satellite CMB data. These results may affect the relationship between superstring theory and supergravity, and the real world. Professor Kallosh works, in particular, on future tests of string theory by CMB data and effective supergravity models with flexible amplitude of gravitational waves produced during inflation.

  • Praveen Kalra

    Praveen Kalra

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine

    BioDr. Praveen Kalra is Board Certified in Anesthesia and in Critical Care. He specializes in trauma, orthopedic, brain and spine surgery, urology, and cancer surgery. He was appointed Fellow of the American Society of Anesthesiology (FASA) in 2023. Appointed Medical Director of Sustainability for Stanford Healthcare in Dec 2023.

    His professional interests include devising protocols for patient safety, informed consent, reducing the impact of anesthetics on the environment, addressing climate change by reducing green house gas emissions in the health care setting, resident education to emphasize evidence based safe care and mentoring medical students. He has been in practice for over 18 years.

    Received the Inaugural Sustainability Ambassador Award in 2022 at SHC for removing Desflurane (anesthetic gas with highest global warming potential) from the OR and undertaking multiple initiatives such as creating a Green Team at SHC, an elective Green Rotation for residents, green curriculum video series and addressing plastic & biohazardous waste in the OR. Current projects are focused on decommissioning nitrous oxide pipelines in the OR. As Medical Director of Sustainability, I work on collaborating with experts, fostering clinician engagement in change management, and spearheading transformative initiatives.

    Dr. Kalra completed his residency in Anesthesia from Harvard Medical School’s Beth Israel Deaconess Hospital and a fellowship in Critical Care from Johns Hopkins Hospital, Baltimore.